LFMD LifeMD, Inc.
LFMD LifeMD, Inc.
Healthcare · Health Information Services
Market read
POC $3.65 · VWAP $4.52 · -26.5% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
LFMD Price Structure
Loading timeframes…
Peers
Every watchlist LFMD belongs to, members best 30-day change first — LFMD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
Reported the quarter ending 2026-03-31: revenue $50M, diluted EPS $-0.20, net income $-9M (SEC filing). Across the print the stock moved -12.5% (close before → first close after).
full note →Against street estimates
How LFMD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about LFMD from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
LFMD research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.